New hope for lung cancer patients: maintenance drug aims to keep disease at bay

NCT ID NCT07242547

First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times

Summary

This study tests a drug called tarlatamab as a maintenance treatment for people with limited-stage small cell lung cancer who cannot receive standard combined chemotherapy and radiation. After completing chemotherapy with or without radiation, participants who have not gotten worse will receive tarlatamab intravenously until their disease progresses or side effects become unacceptable. The main goal is to see how long the drug can delay cancer growth or death.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOMA, SMALL CELL LUNG are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Complejo Hospitalario de Navarra

    RECRUITING

    Pamplona, Navarre, 31008, Spain

  • Fundació Althaia

    RECRUITING

    Manresa, Barcelona, 08243, Spain

  • Hospital Clínic de Barcelona

    RECRUITING

    Barcelona, Barcelona, 08036, Spain

  • Hospital Clínico San Carlos

    RECRUITING

    Madrid, Madrid, 28040, Spain

  • Hospital General Universitario Dr. Balmis de Alicante

    RECRUITING

    Alicante, Alicante, 03010, Spain

  • Hospital General Universitario de Albacete

    RECRUITING

    Albacete, Albacete, 02006, Spain

  • Hospital General Universitario de Elche

    RECRUITING

    Elche, Alicante, 03203, Spain

  • Hospital General Universitario de Valencia

    RECRUITING

    Valencia, Valencia, 46014, Spain

  • Hospital Regional de Málaga

    RECRUITING

    Málaga, Málaga, 29010, Spain

  • Hospital Santa Maria Mai - Complexo Hospitalario Universitario Ourense

    RECRUITING

    Ourense, Ourense, 32005, Spain

  • Hospital Son Espases

    RECRUITING

    Palma de Mallorca, Mallorca, 07120, Spain

  • Hospital Son Llàtzer

    RECRUITING

    Palma de Mallorca, Mallorca, 07198, Spain

  • Hospital Universitari Vall d'Hebron

    RECRUITING

    Barcelona, Barcelona, 08035, Spain

  • Hospital Universitario Fundación Jiménez Díaz

    RECRUITING

    Madrid, Madrid, 28040, Spain

  • Hospital Universitario Lucus Augusti

    RECRUITING

    Lugo, Lugo, 27003, Spain

  • Hospital Universitario Nuestra Señora de Candelaria

    RECRUITING

    Santa Cruz de Tenerife, Tenerife, 38010, Spain

  • Hospital Universitario Puerta de Hierro

    RECRUITING

    Madrid, Madrid, 28222, Spain

  • Hospital Universitario de Jerez de la Frontera

    RECRUITING

    Jerez de la Frontera, Cádiz, 11407, Spain

  • Hospital de Basurto

    RECRUITING

    Bilbao, Bizkaia, 48013, Spain

  • Hospital de la Santa Creu i Sant Pau

    RECRUITING

    Barcelona, Barcelona, 08025, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.